Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication important safety precautions. | AHRQ Patient Safety Network

Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication important safety precautions. | AHRQ Patient Safety Network

• Press Release/Announcement
 
• Published January 2017

Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 11, 2017.

Hazards in the magnetic resonance imaging environment can result in patient harm. This announcement raises awareness of inaccuracies and disruptions that may affect the safety of patients with implantable infusion devices who undergo an MRI exam. The statement recommends that patients inform their care team and carry an implant card with information about the implanted device to prevent these problems.

Free full textRelated information

Related Resources

JOURNAL ARTICLE › COMMENTARY

Changing smart pump vendors: lessons learned.

Arthur KJ, Catlin AC, Quebe A, Washington A. Hosp Pharm. 2016;51:782-789.

WEB RESOURCE › MULTI-USE WEBSITE

Interference between CT and Electronic Medical Devices.

Rockville, MD: Center for Devices and Radiological Health, US Food and Drug Administration. April 12, 2016.

JOURNAL ARTICLE › STUDY

The frequency of intravenous medication administration errors related to smart infusion pumps: a multihospital observational study.

Schnock KO, Dykes PC, Albert J, et al. BMJ Qual Saf. 2017;26:131-140.

NEWSPAPER/MAGAZINE ARTICLE

Managing hospitalized patients with ambulatory pumps: findings from an ISMP survey—Part 1.

ISMP Medication Safety Alert! Acute Care Edition. November 19, 2015;20:1-5.

JOURNAL ARTICLE › STUDY

Rates of safety incident reporting in MRI in a large academic medical center.

Mansouri M, Aran S, Harvey HB, Shaqdan KW, Abujudeh HH. J Magn Reson Imaging. 2016;43:998-1007.

View More